Table 3 Correlation between cancer cell line CES values and IC50s for irinotecan and topotecan in CCLE cancer cell lines.
CCLE cell lines | Irinotecan | Topotecan | ||||
|---|---|---|---|---|---|---|
|  | Spearman’s rho | P value | n | Spearman’s rho | P value | n |
Breast | −0.644 | 0.007* | 16 | −0.247 | 0.281 | 21 |
Lung | −0.419 | 0.005* | 44 | −0.425 | 0.0001* | 77 |
Ovary | −0.623 | 0.003* | 20 | −0.469 | 0.018* | 25 |
Haematopoietic and lymphoid | −0.344 | 0.017* | 48 | −0.092 | 0.468 | 65 |
Skin | 0.200 | 0.327 | 26 | −0.163 | 0.364 | 33 |
CNS | −0.203 | 0.436 | 17 | −0.126 | 0.568 | 23 |
Pancreas | −0.439 | 0.078 | 17 | −0.143 | 0.536 | 21 |
Pooled | −0.384 | <0.000001* | 277 | −0.339 | <0.000001* | 412 |